February 2024
1. LIU C, Zhao X, Wang Z, Zhang C, et al
   LncRNA CHROMR/miR-27b-3p/MET axis promotes the proliferation, invasion and contributes to rituximab resistance in diffuse large B-cell lymphoma.
   J Biol Chem. 2024 Feb 15:105762. doi: 10.1016/j.jbc.2024.105762.
   

   >> Share

   
   November 2023
2. KUMARI N, Das K, Sharma S, Dahal S, et al
   Evaluation of Potential Role of R-Loop and G-quadruplex DNA in the Fragility of c-MYC during Chromosomal Translocation Associated with Burkitt's Lymphoma.
   J Biol Chem. 2023 Nov 3:105431. doi: 10.1016/j.jbc.2023.105431.
   

   >> Share

   
   February 2023
3. CHU L, Tan D, Zhu M, Qu Y, et al
   EZH2 W113C is a gain-of-function mutation in B cell lymphoma enabling both PRC2 methyltransferase activation and tazemetostat resistance.
   J Biol Chem. 2023 Feb 27:103073. doi: 10.1016/j.jbc.2023.103073.
   

   >> Share

   
   September 2022
4. YUAN H, Zhu Y, Cheng Y, Hou J, et al
   BTK kinase activity is dispensable for the survival of diffuse large B-cell lymphoma.
   J Biol Chem. 2022 Sep 29:102555. doi: 10.1016/j.jbc.2022.102555.
   

   >> Share

   
   August 2021
5. LIU H, Lu Z, Shi X, Liu L, et al
   HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
   J Biol Chem. 2021;297:100996.
   

   >> Share

   
   January 2021
6. ZHENG S, Matthews AJ, Rahman N, Herrick-Reynolds K, et al
   The uncharacterized SANT and BTB domain-containing protein SANBR inhibits class switch recombination.
   J Biol Chem. 2021;296:100625.
   

   >> Share

   
   
7. KOKSAL H, Dillard P, Juzeniene A, Kvalheim G, et al
   Combinatorial CAR design improves target restriction.
   J Biol Chem. 2021;296:100116.
   

   >> Share

   
   
8. LOPUSNA K, Nowialis P, Opavska J, Abraham A, et al
   Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
   J Biol Chem. 2021;296:100285.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share